MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 275 filers reported holding MYRIAD GENETICS INC in Q4 2013. The put-call ratio across all filers is 4.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $389,000 | +6.6% | 29,859 | -7.1% | 0.00% | 0.0% |
| Q2 2020 | $365,000 | -26.1% | 32,133 | -7.0% | 0.00% | 0.0% |
| Q1 2020 | $494,000 | -51.1% | 34,562 | -6.9% | 0.00% | -50.0% |
| Q4 2019 | $1,011,000 | +2.1% | 37,142 | +7.4% | 0.00% | -88.2% |
| Q3 2019 | $990,000 | -5.6% | 34,583 | -8.4% | 0.02% | -5.6% |
| Q2 2019 | $1,049,000 | -32.1% | 37,757 | -18.8% | 0.02% | -35.7% |
| Q1 2019 | $1,544,000 | +5.7% | 46,505 | -7.4% | 0.03% | -6.7% |
| Q4 2018 | $1,461,000 | -44.9% | 50,234 | -12.9% | 0.03% | -37.5% |
| Q3 2018 | $2,653,000 | +0.5% | 57,672 | -18.3% | 0.05% | -4.0% |
| Q2 2018 | $2,639,000 | -2.3% | 70,627 | -22.7% | 0.05% | -3.8% |
| Q1 2018 | $2,701,000 | -33.5% | 91,396 | -22.8% | 0.05% | -31.6% |
| Q4 2017 | $4,064,000 | -25.2% | 118,337 | -21.2% | 0.08% | -27.6% |
| Q3 2017 | $5,432,000 | -0.6% | 150,145 | -29.0% | 0.10% | -2.8% |
| Q2 2017 | $5,463,000 | +40.7% | 211,405 | +4.5% | 0.11% | +38.5% |
| Q1 2017 | $3,882,000 | +28.5% | 202,231 | +11.6% | 0.08% | +25.8% |
| Q4 2016 | $3,020,000 | -5.0% | 181,173 | +17.3% | 0.06% | -4.6% |
| Q3 2016 | $3,179,000 | -20.9% | 154,436 | +17.6% | 0.06% | -22.6% |
| Q2 2016 | $4,018,000 | -15.1% | 131,297 | +3.8% | 0.08% | -31.1% |
| Q1 2016 | $4,733,000 | -15.5% | 126,444 | -2.5% | 0.12% | -15.9% |
| Q4 2015 | $5,599,000 | +14.8% | 129,732 | -0.3% | 0.14% | +14.2% |
| Q3 2015 | $4,879,000 | +4.6% | 130,178 | -5.1% | 0.13% | +0.8% |
| Q2 2015 | $4,663,000 | -0.4% | 137,189 | +3.8% | 0.13% | -6.0% |
| Q1 2015 | $4,680,000 | +5.5% | 132,192 | +1.5% | 0.13% | +3.1% |
| Q4 2014 | $4,436,000 | -14.4% | 130,233 | -3.0% | 0.13% | -17.2% |
| Q3 2014 | $5,181,000 | -7.0% | 134,320 | -6.1% | 0.16% | -6.0% |
| Q2 2014 | $5,568,000 | +11.0% | 143,068 | -2.5% | 0.17% | +5.7% |
| Q1 2014 | $5,015,000 | +61.9% | 146,697 | -0.7% | 0.16% | +58.0% |
| Q4 2013 | $3,098,000 | -6.3% | 147,669 | +4.9% | 0.10% | -14.5% |
| Q3 2013 | $3,306,000 | +5.4% | 140,719 | +20.5% | 0.12% | 0.0% |
| Q2 2013 | $3,138,000 | – | 116,777 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |